Announcements Trials
Browse Landscape

Phase

Phase NA 3

Status

Recruiting 1Completed 1Active not recruiting 1

Sponsor Class

OTHER 27INDUSTRY 13OTHER_GOV 3NETWORK 2

Study Type

Interventional 3

Sponsor

Cancer Type

Breast 3

Conditions

Breast Neoplasms 3Disease 1

Interventions

Cisplatin 49Capecitabine 41apatinib 34Gemcitabine 33Oxaliplatin 32Cyclophosphamide 31Radiotherapy 29Paclitaxel 29Carboplatin 29tislelizumab 27Irinotecan 27Drug Therapy 27Fluorouracil 26Docetaxel 26Bevacizumab 23fludarabine 18Surgical Procedures, Operative 17Nivolumab 17pembrolizumab 16Exercise 16Metformin 15camrelizumab 14S 1 (combination) 14Radiation 14Pemetrexed 13Control Groups 12anlotinib 11Leucovorin 11toripalimab 10Vinorelbine 10

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER_GOV × Interventional × Mammography × Clear all
NCT06629896 2026-05-07

CEM

Azienda USL Reggio Emilia - IRCCS

Phase NA Recruiting
2,200 enrolled
Breast

Breast Neoplasms, Disease

NCT02698202 2025-12-19

Screening for Breast Cancer With Digital Breast Tomosynthesis

Azienda USL Reggio Emilia - IRCCS

Phase NA Completed
26,877 enrolled
Breast

Breast Neoplasms

NCT04461808 2025-06-25

MAITA

Azienda USL Reggio Emilia - IRCCS

Phase NA Active not recruiting
10,156 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡